Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients

Condition:   Persistent Asthma Interventions:   Combination Product: fluticasone/formoterol k-haler (medium strength);   Combination Product: Standard of care (ICs/LABA high strength) Sponsors:   Mundipharma Pharmaceuticals S.L.;   Alpha Bioresearch S.L.;   Dynamic Solutions Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

Publication date: Available online 6 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Elena Curto, Alfons Torrego, Noe Garin, Astrid Crespo-Lessmann, Vicente Plaza
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
CONCLUSIONS B. infantis can reduce the infiltration of inflammatory cells induced by OVA-specific antibodies in mice. B. infantis has therapeutic effects on allergic asthma by promoting Th1 and inhibiting Th2 immune responses. PMID: 32249275 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Medical experts are calling for asthmatics to take regular medication during the coronavirus pandemic, as it's not known how 'at risk' the population is.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Conclusions: In our study, among most children, early day care was associated with reduced asthma risk at 7 years, and increased risk in a small group of children with very high underlying susceptibility to asthma.
Source: Epidemiology - Category: Epidemiology Tags: Pulmonary Disease Source Type: research
Source: Patient Preference and Adherence - Category: International Medicine & Public Health Tags: Patient Preference and Adherence Source Type: research
Publication date: Available online 5 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Schleich Florence, Vaia Elleni-Sofia, Pilette Charles, Vandenplas Olivier, Halloy Jean-Luc, Michils Alain, Peche Rudy, Hanon Shane, Louis Renaud, Michel Olivier
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
By Esther NgumbiILLINOIS, United States, Apr 6 2020 (IPS) During a crisis, such as the novel coronavirus, whose impact changes with every passing minute, the urge to listen to and watch the news, and get firsthand insights and real time updates can be constant. Indeed, millions of Americans are frequently checking the news. I know I am. What I’ve noticed on three of the major TV stations I’ve watched across the day is the absence of diversity in the experts commenting on the pandemic. This is inexcusable. The United States is made up of people of many different races and ethnicities, many of whom are profession...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Headlines Health North America TerraViva United Nations Source Type: news
MONDAY, April 6, 2020 -- People taking a certain class of steroids for inflammatory conditions such as asthma, allergies and arthritis may be at increased risk from the new coronavirus, experts say. Glucocorticoid medications suppress the immune...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
The READY study evaluated the effect and the cost benefits of a community health worker-led home intervention on improving outcomes for Medicaid-enrolled children with uncontrolled asthma.Preventing Chronic Disease
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
This observational study examines the pathophysiological changes in the small airways associated with using a fine particle (PM2.5) –removing device in bedrooms of children with asthma.
Source: JAMA Pediatrics - Category: Pediatrics Source Type: research
More News: Asthma | Flonase | Research